Articles From: INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Retrophin, Inc. (RTRX) to Contact the Firm to INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Altisource Portfolio Solutions S.A.


http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G025196-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/10/31/11G025196/mw18sbc71j11nkikt31oqs1bfcl832-1291963499582.jpg NEW YORK, NY--(Marketwired - October 31, 2014) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Retrophin, Inc. ("Retrophin" or the "Company") (NASDAQ: RTRX) of the December 19, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Retrophin and certain executives.
Sign-up for INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Retrophin, Inc. (RTRX) to Contact the Firm investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G025203-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/10/31/11G025203/mw18sbc71j11nkikt31oqs1bfcl832-1291963499582.jpg NEW YORK, NY--(Marketwired - November 01, 2014) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Tesco PLC ("Tesco" or the "Company") (OTC: TSCDY) of the December 23, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Tesco and certain executives.
Sign-up for INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Tesco PLC (TSCDY) to Contact the Firm investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G023670-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/10/10/11G023670/mw18sbc71j11nkikt31oqs1bfcl832-1291963499582.jpg NEW YORK, NY--(Marketwired - October 10, 2014) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Textura Corporation ("Textura" or the "Company") (NYSE: TXTR) of the December 8, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Textura and certain executives.
Sign-up for INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Textura Corporation (TXTR) to Contact the Firm investment picks
2014/10/31
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G025197-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/10/31/11G025197/mw18sbc71j11nkikt31oqs1bfcl832-1291963499582.jpg NEW YORK, NY--(Marketwired - October 31, 2014) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Willbros Group Inc. ("Willbros" or the "Company") (NYSE: WG) of the December 29, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Willbros and certain executives.
Sign-up for INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Willbros Group Inc. (WG) to Contact the Firm investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G023663-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/10/10/11G023663/mw18sbc71j11nkikt31oqs1bfcl832-1291963499582.jpg NEW YORK, NY--(Marketwired - October 10, 2014) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in AcelRx Pharmaceuticals, Inc. ("AcelRx" or the "Company") (NASDAQ: ACRX) of the December 1, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against AcelRx and certain executives.
Sign-up for INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $50,000 Investing in AcelRx Pharmaceuticals, Inc. (ACRX) to Contact the Firm investment picks
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at GT Advanced Technologies, Inc. (“GT” or the “Company”) (NASDAQ: GTAT). On October 6, 2014, GT announced that it and its subsidiaries were filing for bankruptcy court protection.
Sign-up for INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $500,000 Investing In GT Advanced Technologies, Inc. (GTAT) To Contact The Firm investment picks
Glancy Binkow & Goldberg LLP , representing investors of Tesco PLC (“Tesco” or the “Company”) (OTC:TSCDY), has filed a shareholder lawsuit in the United States District Court for the Southern District of New York with an expanded Class Period, including purchasers of Tesco American Depositary Shares (“ADSs”) between January 9, 2014 and October 22, 2014 (the “Class Period”). Tesco operates as a grocery retailer through stores offering food, groceries, clothing and general merchandise.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Announces An Expanded Class Period in the Shareholder Lawsuit Against Tesco PLC investment picks
Glancy Binkow & Goldberg LLP filed a shareholder class action lawsuit on August 22, 2014, in the United States District Court for the Southern District of New York on behalf of purchasers of the securities of EZCORP, Inc .
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Announces Update to the Shareholder Lawsuit Against EZCORP, Inc. investment picks
Glancy Binkow & Goldberg LLP filed a shareholder class action lawsuit on August 13, 2014, in the United States District Court for the Northern District of California on behalf of purchasers of the securities of Impax Laboratories, Inc. (“Impax” or the “Company”) (NASDAQ:IPXL). The complaint alleges that throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (1) Impax failed to maintain proper quality control and manufacturing practices at its Taiwan facility, in violation of current Good Manufacturing Practices; (2) the manufacturing deficiencies at the Taiwan facility could have a material adverse impact on Impax’s ability to successfully launch its new drug, RYTARY, a long-acting capsule to treat the symptoms of Parkinson’s disease; and (3) these deficiencies jeopardized Impax’s ability to manufacture,
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Announces Update to the Shareholder Lawsuit Against Impax Laboratories, Inc. investment picks
Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors in Education Management Corporation (“EDMC” or the “Company”) (NASDAQ: EDMC) between August 8, 2012 and September 16, 2014, inclusive (the “Class Period”). Investors who purchased EDMC securities during the Class Period and wish to serve as a lead plaintiff in the class action must move the Court no later than November 18, 2014.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Investigates Claims on Behalf of Investors of Education Management Corporation investment picks
2014/9/17
Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Fabrinet (the “Company”) (NYSE:FN). The investigation concerns possible violations of federal securities laws and focuses on the Company’s operations and financial performance.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP is Investigating Potential Claims on Behalf of Fabrinet Investors investment picks
Glancy Binkow & Goldberg LLP alerts investors that a class action lawsuit has been filed against Bankrate, Inc. (“Bankrate” or the “Company”) (NYSE: RATE) that expands the class period to include purchases of securities between October 16, 2012 and September 15, 2014, inclusive (the “Class Period”). Investors who purchased Bankrate securities during the Class Period and wish to serve as a lead plaintiff in the class action must move the Court no later than November 17, 2014.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Expanded Class Period and Upcoming Lead Plaintiff Deadline in the Class Action Lawsuit on Behalf of Bankrate, Inc. Investors investment picks
Glancy Binkow & Goldberg LLP reminds investors of AcelRx Pharmaceuticals, Inc. (“AcelRx” or the “Company”) (NASDAQ: ACRX) that those who purchased or otherwise acquired AcelRx’s common stock and/or call options, or sold/wrote AcelRx’s put options between December 2, 2013 and September 25, 2014, inclusive (the “Class Period”), have until December 1, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the Northern District of California.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. investment picks
Glancy Binkow & Goldberg LLP reminds investors of Aeterna Zentaris Inc. (“Aeterna” or the “Company”) (NASDAQ:AEZS) that purchasers of Aeterna securities between October 18, 2012 and November 5, 2014, inclusive (the “Class Period”), have until January 12, 2015, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the District of New Jersey.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Aeterna Zentaris Inc. investment picks
Glancy Binkow & Goldberg LLP reminds investors of Albany Molecular Research Inc. (“Albany Molecular” or the “Company”) (NASDAQ:AMRI) that purchasers of Albany Molecular common stock between August 5, 2014 and November 5, 2014, inclusive (the “Class Period”), have until January 12, 2015, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit Albany Molecular is a contract research and manufacturing company that provides integrated drug discovery, development and manufacturing services primarily in the United States, Europe and Asia.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Albany Molecular Research Inc. investment picks
2014/10/22
Glancy Binkow & Goldberg LLP reminds investors of Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ:ASPS) that purchasers of Altisource common stock between July 25, 2013 and August 4, 2014, inclusive (the “Class Period”), have until November 7, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Altisource Portfolio Solutions S.A. investment picks
2014/10/17
Glancy Binkow & Goldberg LLP reminds investors of Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ:ASPS) that purchasers of Altisource common stock between July 25, 2013 and August 4, 2014, inclusive (the “Class Period”), have until November 7, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Altisource Portfolio Solutions S.A. investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Retrophin, Inc. (RTRX) to Contact the Firm to INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Altisource Portfolio Solutions S.A.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent